These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10521060)
1. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060 [TBL] [Abstract][Full Text] [Related]
5. Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug. Mishra T; Shokr M; Ahmed A; Afonso L BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519717 [TBL] [Abstract][Full Text] [Related]
6. The spectrum of 5-fluorouracil cardiotoxicity. Dalzell JR; Samuel LM Anticancer Drugs; 2009 Jan; 20(1):79-80. PubMed ID: 19353811 [TBL] [Abstract][Full Text] [Related]
7. Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer. Franck C; Malfertheiner P; Venerito M BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536214 [TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil cardiotoxicity: reversible left ventricular systolic dysfunction with early detection. Iskandar MZ; Quasem W; El-Omar M BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25935919 [TBL] [Abstract][Full Text] [Related]
9. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death. Wijesinghe N N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205 [TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil induced cardiotoxicity: review of the literature. Sorrentino MF; Kim J; Foderaro AE; Truesdell AG Cardiol J; 2012; 19(5):453-8. PubMed ID: 23042307 [TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of 5-fluorouracil. Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Jensen SA; Sørensen JB Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875 [TBL] [Abstract][Full Text] [Related]
13. 5-Flourouracil cardiotoxicity - an elusive cardiopathy: case report. Bhat GM; Mir MH; Showkat HI; Kasanna B; Bagdadi F; Sarmast AH; Qadri S Gulf J Oncolog; 2012 Jul; (12):70-2. PubMed ID: 22773220 [TBL] [Abstract][Full Text] [Related]
14. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature. Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673 [TBL] [Abstract][Full Text] [Related]
15. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity. Shaib W; Lee V; Saif MW In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Porta C; Moroni M; Ferrari S; Nastasi G Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887 [TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of the antiproliferative compound fluorouracil. Becker K; Erckenbrecht JF; Häussinger D; Frieling T Drugs; 1999 Apr; 57(4):475-84. PubMed ID: 10235688 [TBL] [Abstract][Full Text] [Related]